When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Updated results from Part 1 of a Phase 2 clinical trial, PIONEER, evaluating Blueprint Medicines' (BPMC+4.9%) lead drug avapritinib (BLU-285) in patients with indolent systemic mastocytosis (SM) showed encouraging action.
More news on: Blueprint Medicines Corporation, Healthcare stocks news, Stocks on the move,